EPS for TrueCar, Inc. (TRUE) forecasted at $-0.06

Nasdaq” with a publish date: January 11, 2019, “Bermekimab Successfully Treats Hidradenitis Suppurativa, Including Significant Reduction in Pain …

Source link

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *